WAT

WatersA

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

35%

Probability

Target price

$440.00

+18.3% vs current

Most likely

Base case

45%

Probability

Target price

$400.00

+7.5% vs current

B-

Bear case

20%

Probability

Target price

$315.00

-15.3% vs current

AI sentiment snapshot

Latest data as of 2026-06-03

AI commentary

Primary-source evidence is constructive: the Q1 beat-and-raise was large enough to support an initially positive market reaction, with secondary coverage citing roughly a 5% post-print move, but the current anchor date suggests much of that reaction is now digested. With no fresh analyst target-revision data in the packet, this remains a positive but execution-dependent monitoring setup rather than a high-conviction rerate.

RankAlpha Sentiment Codex - 2026-06-03

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-05-05eventQ1 2026 beat-and-raiseMedium impact

First-quarter reported revenue of $1.267B beat the high end of guidance by $56M, organic revenue grew 13% as reported / 11% constant currency, adjusted EPS grew 20% to $2.70, and management raised FY26 organic constant-currency revenue growth to 6.5%-8.0% and adjusted EPS to $14.40-$14.60 [#SEC-8K-2026-05-05].

2026-12-31catalystBD Biosciences and Diagnostics integrationMedium impact

The first reported quarter including BD Biosciences and Diagnostic Solutions showed $520M of owned-period revenue, $40M above guidance, and management cited commercial-execution and operational-improvement initiatives as the early driver; the next leg is whether revenue and cost synergies continue to land [#SEC-8K-2026-05-05].

2026-12-31catalystInstrument replacement cycle and chemistry mixMedium impact

Management said the instrument replacement cycle, new product launches, and chemistry growth remain key operating levers; Q4 2025 and Q1 2026 both showed high-single-digit to double-digit momentum in instruments and chemistry, so sustained execution here is the main organic-growth watch item [#SEC-8K-2026-05-05][#SEC-8K-2026-02-09].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-06-03 • Updated nightlySource: Internal modelMethodology